These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1149361)

  • 21. Elimination of furosemide in healthy subjects and in those with renal failure.
    Beermann B; Dalén E; Lindström B
    Clin Pharmacol Ther; 1977 Jul; 22(1):70-8. PubMed ID: 872498
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Consequences of renal insufficiency on the hepatic clearance of some drugs.
    Balant LP; Dayer P; Fabre J
    Int J Clin Pharmacol Res; 1983; 3(6):459-74. PubMed ID: 6147317
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of serum creatinine measurement error on dose adjustment in renal failure.
    Schneider V; Henschel V; Tadjalli-Mehr K; Mansmann U; Haefeli WE
    Clin Pharmacol Ther; 2003 Nov; 74(5):458-67. PubMed ID: 14586386
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Pharmacokinetics of azlocillin in chronic renal failure and hemodialysis patients].
    Fillastre JP; Humbert G; Leroy A; Godin M
    Presse Med; 1984 Mar; 13(13):797-801. PubMed ID: 6231597
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics of cefadroxil in normal subjects and in patients with renal insufficiency.
    Humbert G; Leroy A; Fillastre JP; Godin M
    Chemotherapy; 1979; 25(4):189-95. PubMed ID: 456077
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prediction of Clearance, Volume of distribution, and Half-life of Drugs in Extremely Low to Low Birth Weight Neonates: An Allometric Approach.
    Mahmood I
    Eur J Drug Metab Pharmacokinet; 2017 Aug; 42(4):601-610. PubMed ID: 27562171
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Disposition kinetics of dibekacin in normal subjects and in patients with renal failure.
    Arancibia A; Chávez J; Ibarra R; Ruiz I; Icarte A; Thambo S; Chávez H
    Int J Clin Pharmacol Ther Toxicol; 1987 Jan; 25(1):38-43. PubMed ID: 3557728
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Digoxin pharmacokinetics: role of renal failure in dosage regimen design.
    Koup JR; Jusko WJ; Elwood CM; Kohli RK
    Clin Pharmacol Ther; 1975 Jul; 18(1):9-21. PubMed ID: 1149366
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pharmacokinetic bases of dosage adaptation of drugs in renal insufficiency].
    Lesne M
    J Pharm Belg; 1988; 43(3):212-32. PubMed ID: 3171871
    [No Abstract]   [Full Text] [Related]  

  • 30. Differential effect of chronic renal failure on the pharmacokinetics of lidocaine in patients receiving and not receiving hemodialysis.
    De Martin S; Orlando R; Bertoli M; Pegoraro P; Palatini P
    Clin Pharmacol Ther; 2006 Dec; 80(6):597-606. PubMed ID: 17178261
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Estimation of drug elimination in renal failure.
    Perrier D; Gibaldi M
    J Clin Pharmacol; 1973; 13(11):458-62. PubMed ID: 4490668
    [No Abstract]   [Full Text] [Related]  

  • 32. Pharmacokinetics of buflomedil after intravenous administration in patients with chronic renal failure.
    Rey E; d'Athis P; Richard MO; Fillastre JP; Olive G
    Int J Clin Pharmacol Ther Toxicol; 1984 Dec; 22(12):648-52. PubMed ID: 6526539
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of chronic renal failure on kidney drug transporters and cytochrome P450 in rats.
    Naud J; Michaud J; Beauchemin S; Hébert MJ; Roger M; Lefrancois S; Leblond FA; Pichette V
    Drug Metab Dispos; 2011 Aug; 39(8):1363-9. PubMed ID: 21525170
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics of cefazolin in normal and uremic subjects.
    Welling PG; Craig WA; Gordon AL; Kunin CM
    Clin Pharmacol Ther; 1974 Apr; 15(4):344-53. PubMed ID: 4821438
    [No Abstract]   [Full Text] [Related]  

  • 35. Elimination half-life of drugs: value and limitations.
    Greenblatt DJ
    Annu Rev Med; 1985; 36():421-7. PubMed ID: 3994325
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetic effects of altered plasma protein binding of drugs in renal disease.
    Keller F; Maiga M; Neumayer HH; Lode H; Distler A
    Eur J Drug Metab Pharmacokinet; 1984; 9(3):275-82. PubMed ID: 6519129
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The one-point method in predicting dosage regimen in case of hepatic and/or renal failure in presence or absence of change in volume of distribution.
    Ritschel WA; Thompson GA
    J Clin Pharmacol; 1979 Jul; 19(7):350-6. PubMed ID: 479379
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Some determinants of the distribution of penicillins and cephalosporins in the body. Practical and theoretical considerations.
    Barza M; Weinstein L
    Ann N Y Acad Sci; 1974 May; 235(0):613-20. PubMed ID: 4527978
    [No Abstract]   [Full Text] [Related]  

  • 39. [Elimination kinetics and dosage of digoxin in patients in renal failure (author's transl)].
    Ohnhaus EE; Spring P; Dettli L
    Dtsch Med Wochenschr; 1974 Sep; 99(37):1797-803. PubMed ID: 4457307
    [No Abstract]   [Full Text] [Related]  

  • 40. Drug distribution in renal failure.
    Gibaldi M
    Am J Med; 1977 Apr; 62(4):471-4. PubMed ID: 851115
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.